Thirdly , theres also a patent application (IN202047010224) (pdf) pending by Novo Nordisk, filed in 2020 with priority date of 24/08/2017, for a specific formulation of semaglutide (the active ingredient in its commercial blockbuster drug, Ozempic) described as Semaglutide liquid formulations (no more than 0.01% (w/w) phenol. Adding to the complexity is a recent revocation petition filed by DRL in May 2025 (as reported by the media here)
In a study of 2,000 participants, those who combined semaglutide with diet and exercise lost an average of 15% of their body weight after 68 weeks, with nearly one-third losing 20%
These medications undergo meticulous FDA scrutiny and have established safety records backed by extensive clinical trials
Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB
Heliyon 6 (10) Nadri P, Zahmatkesh A, Bakhtari A (2024) The potential effect of melatonin on in vitro oocyte maturation and embryo development in animals